Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood-based injections offer new hope for women with bladder leaks

NCT ID NCT07366762

Disease control Sponsor: Kafrelsheikh University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two injections made from a woman's own blood (platelet-rich plasma and platelet-rich fibrin) to treat stress urinary incontinence—leaking urine when coughing, sneezing, or exercising. Forty women aged 30-75 who could not or did not want surgery received one of the two injections around the urethra. The goal was to see which injection better reduced leakage and improved quality of life, and whether repeat injections were needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

40 people

The number who actually took part.

Started

Jul 2024

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 75 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients with primary symptoms of SUI confirmed by patient's medical history and clinical examination, including a focused incontinence evaluation * Age range of 30-75 years * Females unfit for surgery * Females with SUI recurrence after previous surgical procedure by suburethal sling * Females refusing surgical interventions Exclusion Criteria: * Residual urine volume exceeding 100 cc after excretion * Evidence of detrusor over-activity on the urodynamic test * Active urinary tract or vaginal infection * Malignancies of the genitourinary system * Patients with genitourinary fistula or urethral diverticulum

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Female stress urinary incontinence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female stress incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Female stress urinary incontinence

Contacts and locations

Locations

  • Kafr Elsheikh University Hospital

    Kafr ash Shaykh, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.